Trial Profile
Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-Metered Dry Powder Inhaler, Symbicort Turbuhaler; an Open, Single Center, Single Dose Study With 3-Way Crossover Design in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2009
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary) ; Charcoal
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors Orion
- 14 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Aug 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
- 23 Jun 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov